Tillotts Pharma AG

Asacol

Asacol

Asacol™ (mesalazine) is a medicine for the treatment of the inflamed lining of the large bowel (colonic and rectal mucosa) and is prescribed as a first-line treatment for mild to moderate ulcerative colitis (UC). Asacol is available in tablets in 400 and 800 mg strengths as well as enemas and suppositories.

Asacol is available in 50 countries worldwide as Asacol and as Octasa®, Asacolon™ and Fivasa™ in the UK, Ireland and France, respectively. Specific indications and instructions for use vary by country.

Asacol™ 1600mg

Asacol 1600 mg (mesalazine) incorporates the modern OPTICORE technology and is indicated for the treatment of mild to moderate UC. Asacol 1600 is currently available in Denmark, Iceland and Norway under the brand name Asacol and in the Netherlands under the brand name Yaldigo.

Asacol 1600: Important information on ASACOL™ 1600 mg and its use can be found in the summary of product characteristics (SmPC)